{"symbol": "CNCE", "companyName": "Concert Pharmaceuticals Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.concertpharma.com", "description": "Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It aims to discover and develop small-molecule drugs for new treatments to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, and Alzheimer's agitation.", "CEO": "Roger D. Tung", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}